Works by Zaveri, Nurulain

Results: 32

Evaluation of Resveratrol, Green Tea Extract, Curcumin, Oxaloacetic Acid, and Medium-Chain Triglyceride Oil on Life Span of Genetically Heterogeneous Mice.

Published in:

Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2013, v. 68, n. 1, p. 6, doi. 10.1093/gerona/gls070

By:

Strong, Randy;
Miller, Richard A.;
Astle, Clinton M.;
Baur, Joseph A.;
de Cabo, Rafael;
Fernandez, Elizabeth;
Guo, Wen;
Javors, Martin;
Kirkland, James L.;
Nelson, James F.;
Sinclair, David A.;
Teter, Bruce;
Williams, David;
Zaveri, Nurulain;
Nadon, Nancy L.;
Harrison, David E.

Publication type:

Article

Functional Selectivity Does Not Predict Antinociceptive/Locomotor Impairing Potencies of NOP Receptor Agonists.

Published in:

Frontiers in Neuroscience, 2021, v. 15, p. N.PAG, doi. 10.3389/fnins.2021.657153

By:

Azevedo Neto, Joaquim;
Ruzza, Chiara;
Sturaro, Chiara;
Malfacini, Davide;
Pacifico, Salvatore;
Zaveri, Nurulain T.;
Calò, Girolamo

Publication type:

Article

Knock-In Mice with NOP-eGFP Receptors Identify Receptor Cellular and Regional Localization.

Published in:

Journal of Neuroscience, 2015, v. 35, n. 33, p. 11682, doi. 10.1523/JNEUROSCI.5122-14.2015

By:

Akihiko Ozawa;
Brunori, Gloria;
Mercatelli, Daniela;
Jinhua Wu;
Cippitelli, Andrea;
Bende Zou;
Xinmin (Simon) Xie;
Williams, Melissa;
Zaveri, Nurulain T.;
Low, Sarah;
Scherrer, Grégory;
Kieffer, Brigitte L.;
Toll, Lawrence

Publication type:

Article

Functional characterization of AT-1001, an α3β4 nicotinic acetylcholine receptor ligand, at human α3β4 and α4β2 nAChR.

Published in:

2015

By:

Zaveri, Nurulain T;
Bertrand, Sonia;
Yasuda, Dennis;
Bertrand, Daniel

Publication type:

journal article

Radiosynthesis of a <sup>125</sup>I analog of a highly selective alpha3beta4 nicotinic acetylcholine receptor antagonist ligand for use in autoradiography studies.

Published in:

Journal of Labelled Compounds & Radiopharmaceuticals, 2012, v. 55, n. 5, p. 177, doi. 10.1002/jlcr.2923

By:

Jiang, Faming;
Bupp, James;
Rhee, Sung;
Toll, Lawrence;
Zaveri, Nurulain T.

Publication type:

Article

Preclinical pharmacokinetic, toxicological and biomarker evaluation of SR16157, a novel dual-acting steroid sulfatase inhibitor and selective estrogen receptor modulator.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1341, doi. 10.1007/s00280-010-1430-x

By:

Rausch, Linda;
Green, Carol;
Steinmetz, Karen;
LeValley, Sue;
Catz, Paul;
Zaveri, Nurulain;
Schweikart, Karen;
Tomaszewski, Joseph;
Mirsalis, Jon

Publication type:

Article

Rodent motor and neuropsychological behaviour measured in home cages using the integrated modular platform Smart Cage<sup>™</sup>.

Published in:

Clinical & Experimental Pharmacology & Physiology, 2012, v. 39, n. 7, p. 614, doi. 10.1111/j.1440-1681.2012.05719.x

By:

Khroyan, Taline V;
Zhang, Jingxi;
Yang, Liya;
Zou, Bende;
Xie, James;
Pascual, Conrado;
Malik, Adam;
Xie, Julian;
Zaveri, Nurulain T;
Vazquez, Jacqueline;
Polgar, Willma;
Toll, Lawrence;
Fang, Jidong;
Xie, Xinmin

Publication type:

Article

Regulator of G‐Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for l‐Dopa‐induced dyskinesia.

Published in:

British Journal of Pharmacology, 2023, v. 180, n. 7, p. 927, doi. 10.1111/bph.15730

By:

Pisanò, Clarissa A.;
Mercatelli, Daniela;
Mazzocchi, Martina;
Brugnoli, Alberto;
Morella, Ilaria;
Fasano, Stefania;
Zaveri, Nurulain T.;
Brambilla, Riccardo;
O'Keeffe, Gerard W.;
Neubig, Richard R.;
Morari, Michele

Publication type:

Article

Cardiovascular and renal effects of novel nonpeptide nociceptin opioid peptide receptor agonists.

Published in:

2022

By:

Denys, Ian B.;
Gao, Juan;
Sutphen, Jane C.;
Zaveri, Nurulain T.;
Kapusta, Daniel R.

Publication type:

journal article

Managing Parkinson's disease: moving ON with NOP.

Published in:

2020

By:

Mercatelli, Daniela;
Bezard, Erwan;
Eleopra, Roberto;
Zaveri, Nurulain T.;
Morari, Michele

Publication type:

journal article

Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists.

Published in:

2018

By:

Arcuri, Ludovico;
Novello, Salvatore;
Frassineti, Martina;
Mercatelli, Daniela;
Pisanò, Clarissa Anna;
Morella, Ilaria;
Fasano, Stefania;
Journigan, Blair V.;
Meyer, Michael E.;
Polgar, Willma E.;
Brambilla, Riccardo;
Zaveri, Nurulain T.;
Morari, Michele

Publication type:

journal article

AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology.

Published in:

2015

By:

Cippitelli, Andrea;
Wu, Jinhua;
Gaiolini, Kelly A;
Mercatelli, Daniela;
Schoch, Jennifer;
Gorman, Michelle;
Ramirez, Alejandra;
Ciccocioppo, Roberto;
Khroyan, Taline V;
Yasuda, Dennis;
Zaveri, Nurulain T;
Pascual, Conrado;
Xie, Xinmin Simon;
Toll, Lawrence

Publication type:

journal article

AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology.

Published in:

British Journal of Pharmacology, 2015, v. 172, n. 7, p. 1834, doi. 10.1111/bph.13034

By:

Cippitelli, Andrea;
Wu, Jinhua;
Gaiolini, Kelly A;
Mercatelli, Daniela;
Schoch, Jennifer;
Gorman, Michelle;
Ramirez, Alejandra;
Ciccocioppo, Roberto;
Khroyan, Taline V;
Yasuda, Dennis;
Zaveri, Nurulain T;
Pascual, Conrado;
Xie, Xinmin (Simon);
Toll, Lawrence

Publication type:

Article

A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates.

Published in:

Science Translational Medicine, 2018, v. 10, n. 456, p. 1, doi. 10.1126/scitranslmed.aar3483

By:

Ding, Huiping;
Kiguchi, Norikazu;
Yasuda, Dennis;
Daga, Pankaj R.;
Polgar, Willma E.;
Lu, James J.;
Czoty, Paul W.;
Kishioka, Shiroh;
Zaveri, Nurulain T.;
Ko, Mei-Chuan

Publication type:

Article

Structure-Based SAR in the Design of Selective or Bifunctional Nociceptin (NOP) Receptor Agonists.

Published in:

AAPS Journal, 2021, v. 23, n. 3, p. 1, doi. 10.1208/s12248-021-00589-7

By:

Meyer, Michael E.;
Doshi, Arpit;
Yasuda, Dennis;
Zaveri, Nurulain T.

Publication type:

Article

Small-molecule agonists and antagonists of the opioid receptor-like receptor (ORL1, NOP): Ligand-based analysis of structural factors influencing intrinsic activity at NOP.

Published in:

AAPS Journal, 2005, v. 7, n. 2, p. E345, doi. 10.1208/aapsj070234

By:

Zaveri, Nurulain;
Jiang, Faming;
Olsen, Cris;
Polgar, Willma;
Toll, Lawrence

Publication type:

Article

A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer.

Published in:

Breast Cancer Research & Treatment, 2007, v. 106, n. 2, p. 191, doi. 10.1007/s10549-007-9494-y

By:

Louise Rasmussen;
Nurulain Zaveri;
Jan Stenvang;
Richard Peters;
Anne Lykkesfeldt

Publication type:

Article

Comparison of the Reinforcing Properties of Nicotine and Cigarette Smoke Extract in Rats.

Published in:

Neuropsychopharmacology, 2014, v. 39, n. 8, p. 1843, doi. 10.1038/npp.2014.31

By:

Costello, Matthew R;
Reynaga, Daisy D;
Mojica, Celina Y;
Zaveri, Nurulain T;
Belluzzi, James D;
Leslie, Frances M

Publication type:

Article

AT-1001: A High Affinity and Selective α3β4 Nicotinic Acetylcholine Receptor Antagonist Blocks Nicotine Self-Administration in Rats.

Published in:

Neuropsychopharmacology, 2012, v. 37, n. 6, p. 1367, doi. 10.1038/npp.2011.322

By:

Toll, Lawrence;
Zaveri, Nurulain T;
Polgar, Willma E;
Jiang, Faming;
Khroyan, Taline V;
Zhou, Wei;
Xie, Xinmin (Simon);
Stauber, Gregory B;
Costello, Matthew R;
Leslie, Frances M

Publication type:

Article

Effect of chronic delivery of the NOP/MOR partial agonist AT-201 and NOP antagonist J-113397 on heroin relapse in a rat model of opioid maintenance.

Published in:

Psychopharmacology, 2024, v. 241, n. 12, p. 2497, doi. 10.1007/s00213-024-06678-7

By:

Bossert, Jennifer M.;
Caldwell, Kiera E.;
Korah, Hannah;
Batista, Ashley;
Bonbrest, Hannah;
Fredriksson, Ida;
Jackson, Shelley N.;
Sulima, Agnieszka;
Rice, Kenner C.;
Zaveri, Nurulain T.;
Shaham, Yavin

Publication type:

Article

Differential regulation of alcohol taking and seeking by antagonism at α4β2 and α3β4 nAChRs.

Published in:

Psychopharmacology, 2018, v. 235, n. 6, p. 1745, doi. 10.1007/s00213-018-4883-y

By:

Cippitelli, Andrea;
Brunori, Gloria;
Schoch, Jennifer;
Armishaw, Christopher J.;
Wu, Jinhua;
Zaveri, Nurulain T.;
Giulianotti, Marc A.;
Welmaker, Gregory S.;
Toll, Lawrence

Publication type:

Article

Homology modeling and molecular dynamics simulations of the active state of the nociceptin receptor reveal new insights intoagonist binding and activation.

Published in:

Proteins, 2012, v. 80, n. 8, p. 1948, doi. 10.1002/prot.24077

By:

Daga, Pankaj R.;
Zaveri, Nurulain T.

Publication type:

Article

NOP receptor pharmacological profile – A dynamic mass redistribution study.

Published in:

PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0203021

By:

Malfacini, Davide;
Simon, Katharina;
Trapella, Claudio;
Guerrini, Remo;
Zaveri, Nurulain T.;
Kostenis, Evi;
Calo’, Girolamo

Publication type:

Article

Synthesis and biological activities of tetrahydroquinazoline analogs of aminopterin and methotrexate.

Published in:

Journal of Heterocyclic Chemistry, 1995, v. 32, n. 1, p. 243, doi. 10.1002/jhet.5570320141

By:

Gangjee, Aleem;
Zaveri, Nurulain;
Queener, Sherry F.;
Kisliuk, Roy L.

Publication type:

Article

Agonist-selective NOP receptor phosphorylation correlates in vitro and in vivo and reveals differential post-activation signaling by chemically diverse agonists.

Published in:

Science Signaling, 2019, v. 12, n. 574, p. N.PAG, doi. 10.1126/scisignal.aau8072

By:

Mann, Anika;
Moulédous, Lionel;
Froment, Carine;
O'Neill, Patrick R.;
Dasgupta, Pooja;
Günther, Thomas;
Brunori, Gloria;
Kieffer, Brigitte L.;
Toll, Lawrence;
Bruchas, Michael R.;
Zaveri, Nurulain T.;
Schulz, Stefan

Publication type:

Article

Potent and selective NOP receptor activation reduces cocaine self-administration in rats by lowering hedonic set point.

Published in:

2020

By:

Cippitelli, Andrea;
Barnes, Megan;
Zaveri, Nurulain T.;
Toll, Lawrence

Publication type:

journal article

Buprenorphine requires concomitant activation of NOP and MOP receptors to reduce cocaine consumption.

Published in:

2018

By:

Kallupi, Marsida;
Shen, Qianwei;
de Guglielmo, Giordano;
Yasuda, Dennis;
Journigan, V. Blair;
Zaveri, Nurulain T.;
Ciccocioppo, Roberto

Publication type:

journal article

Attenuated G protein signaling and minimal receptor phosphorylation as a biochemical signature of low side-effect opioid analgesics.

Published in:

Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-11189-6

By:

Dasgupta, Pooja;
Mann, Anika;
Polgar, Willma E.;
Reinscheid, Rainer K.;
Zaveri, Nurulain T.;
Schulz, Stefan

Publication type:

Article

The Nociceptin Receptor (NOP) Agonist AT-312 Blocks Acquisition of Morphine- and Cocaine-Induced Conditioned Place Preference in Mice.

Published in:

Frontiers in Psychiatry, 2018, p. N.PAG, doi. 10.3389/fpsyt.2018.00638

By:

Zaveri, Nurulain T.;
Marquez, Paul V.;
Meyer, Michael E.;
Hamid, Abdul;
Lutfy, Kabirullah

Publication type:

Article

Orphanin FQ/Nociceptin Activates Nuclear Factor Kappa B.

Published in:

Journal of NeuroImmune Pharmacology, 2011, v. 6, n. 4, p. 617, doi. 10.1007/s11481-011-9279-2

By:

Donica, Courtney;
Ramirez, Vanessa;
Awwad, Hibah;
Zaveri, Nurulain;
Toll, Lawrence;
Standifer, Kelly

Publication type:

Article

Probing ligand recognition of the opioid pan antagonist AT-076 at nociceptin, kappa, mu, and delta opioid receptors through structure-activity relationships.

Published in:

Scientific Reports, 2017, v. 7, n. 1, p. 1, doi. 10.1038/s41598-017-13129-1

By:

Journigan, V. Blair;
Polgar, Willma E.;
Tuan, Edward W.;
Lu, James;
Daga, Pankaj R.;
Zaveri, Nurulain T.

Publication type:

Article

A key role for the N/OFQ-NOP receptor system in modulating nicotine taking in a model of nicotine and alcohol co-administration.

Published in:

Scientific Reports, 2016, p. 26594, doi. 10.1038/srep26594

By:

Cippitelli, Andrea;
Schoch, Jennifer;
Debevec, Ginamarie;
Brunori, Gloria;
Zaveri, Nurulain T.;
Toll, Lawrence

Publication type:

Article